Hospital
Richmond Medical Center
Richmond Medical Center was paid $138.85M by Medicaid between Jan 2018 and Dec 2024, across 310 billing codes. Its largest line is 90832, psychotherapy session, about 30 minutes — 19% of everything it billed.
33Billing provider infoRICHMOND MEDICAL CENTER
STATEN ISLAND, NY 10310
STATEN ISLAND, NY 10310
33aNPI1740389154assigned 09/22/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$138.85M
24GClaims1,319,760
24DCodes billed310
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in New York
Rank by total paid#2 of 33
Median peer was paid$171K
This provider vs. median813×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,085 | $967K | |
| 2019 | 105,447 | $7.36M | |
| 2020 | 258,142 | $19.31M | |
| 2021 | 269,632 | $21.77M | |
| 2022 | 253,777 | $37.93M | |
| 2023 | 235,115 | $33.62M | |
| 2024incomplete | 174,562 | $17.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 19% | 186,112 | 86,119 | $26.23M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 9.5% | 19,887 | 14,968 | $13.16M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.8% | 64,630 | 55,665 | $10.81M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.0% | 44,737 | 40,326 | $9.71M |
| H2012 | Behavioral health day treatment, per hour | 6.1% | 82,861 | 5,720 | $8.43M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 31,114 | 28,895 | $6.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.2% | 34,616 | 31,525 | $5.87M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.6% | 26,461 | 13,954 | $5.04M |
| 36415 | Collection of venous blood by venipuncture | 3.6% | 111,489 | 53,269 | $4.94M |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 1.6% | 19,212 | 5,795 | $2.26M |
| G0378 | Hospital observation service, per hour | 1.6% | 6,601 | 3,965 | $2.19M |
| S9485 | Crisis intervention mental health services, per diem | 1.5% | 1,786 | 1,679 | $2.04M |
298 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 9,381 | $1.96M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 13,286 | $1.87M |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 1.3% | 12,583 | $1.74M |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.2% | 3,856 | $1.71M |
| H0037 | Community psychiatric supportive treatment program, per diem | 1.2% | 1,370 | $1.68M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 6,934 | $1.61M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 6,244 | $1.50M |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 7,879 | $1.28M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,136 | $1.10M |
| 99285 | Emergency room visit (most serious) | <1% | 7,160 | $1.05M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,362 | $1.04M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 6,907 | $1.02M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 750 | $1.00M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 5,009 | $989K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,067 | $867K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,468 | $842K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 2,545 | $764K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 8,604 | $760K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,761 | $750K |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | <1% | 439 | $728K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16,577 | $711K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 19,023 | $689K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,571 | $669K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 2,421 | $638K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 10,393 | $631K |
| 80053 | Comprehensive metabolic panel | <1% | 37,491 | $618K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,571 | $602K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,338 | $594K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,042 | $522K |
| 93970 | <1% | 1,363 | $509K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 10,131 | $492K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,583 | $479K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,764 | $453K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 9,278 | $438K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 5,059 | $419K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,552 | $404K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,074 | $381K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,623 | $365K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,986 | $342K |
| 86850 | <1% | 7,095 | $326K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 6,899 | $307K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,372 | $278K |
| 12001 | <1% | 524 | $252K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,548 | $245K |
| 76818 | <1% | 1,400 | $233K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,533 | $231K |
| 97161 | <1% | 1,346 | $207K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,470 | $202K |
| 81025 | <1% | 9,435 | $186K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,228 | $185K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,970 | $178K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,793 | $172K |
| 86901 | <1% | 7,114 | $157K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 533 | $152K |
| 87800 | <1% | 2,777 | $152K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,609 | $151K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,239 | $137K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,859 | $134K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 873 | $130K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,963 | $129K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,312 | $113K |
| 86900 | <1% | 7,082 | $113K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 686 | $107K |
| 76830 | Ultrasound, transvaginal | <1% | 2,025 | $105K |
| 12011 | <1% | 224 | $102K | |
| 90686 | <1% | 5,130 | $101K | |
| 80061 | Lipid panel | <1% | 7,550 | $94K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 9,180 | $91K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,697 | $73K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,734 | $71K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 470 | $71K |
| 83880 | <1% | 3,381 | $68K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 2,613 | $66K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 446 | $66K |
| 67924 | <1% | 38 | $63K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 411 | $62K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,014 | $57K |
| 90715 | <1% | 2,604 | $56K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 356 | $56K |
| 85027 | <1% | 41,696 | $52K | |
| 29540 | <1% | 204 | $49K | |
| 70486 | <1% | 1,036 | $49K | |
| 88312 | <1% | 1,030 | $46K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,827 | $44K |
| 85610 | <1% | 11,028 | $43K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 37 | $43K |
| 83655 | <1% | 3,346 | $42K | |
| 99402 | <1% | 654 | $42K | |
| 12002 | <1% | 91 | $42K | |
| 90651 | <1% | 1,030 | $42K | |
| 72131 | <1% | 401 | $41K | |
| 86703 | <1% | 2,840 | $40K | |
| 86480 | <1% | 634 | $39K | |
| 10060 | <1% | 94 | $39K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 322 | $37K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,342 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,284 | $35K |
| 82803 | <1% | 2,302 | $35K | |
| 96112 | <1% | 510 | $34K | |
| 76775 | <1% | 371 | $32K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 143 | $32K |
| 76801 | <1% | 274 | $31K | |
| 3E0234Z | <1% | 40 | $31K | |
| 92015 | Determination of refractive state | <1% | 711 | $31K |
| 87631 | <1% | 684 | $30K | |
| 90670 | <1% | 1,764 | $30K | |
| 92523 | <1% | 125 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,983 | $30K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 512 | $28K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 80 | $27K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 337 | $26K |
| 11721 | <1% | 208 | $22K | |
| 58558 | <1% | 14 | $22K | |
| 80076 | <1% | 2,282 | $21K | |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 209 | $21K |
| 85730 | <1% | 9,281 | $20K | |
| 88304 | <1% | 379 | $18K | |
| 76536 | <1% | 377 | $18K | |
| 90633 | <1% | 890 | $18K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 39 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 720 | $17K |
| 88342 | <1% | 134 | $17K | |
| 84439 | <1% | 2,782 | $17K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 216 | $17K |
| 82962 | <1% | 5,640 | $16K | |
| 29125 | <1% | 57 | $16K | |
| 90734 | <1% | 693 | $16K | |
| 0002A | <1% | 848 | $16K | |
| 99381 | <1% | 95 | $15K | |
| 82607 | <1% | 1,390 | $14K | |
| 81003 | <1% | 14,246 | $14K | |
| 90648 | <1% | 891 | $13K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,185 | $13K |
| H0033 | Oral medication administration, direct observation | <1% | 515 | $13K |
| S9484 | Crisis intervention mental health services, per hour | <1% | 15 | $13K |
| 93017 | <1% | 43 | $12K | |
| 90681 | <1% | 751 | $12K | |
| 71250 | <1% | 95 | $12K | |
| 36430 | <1% | 28 | $11K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 39 | $11K |
| 73630 | <1% | 1,518 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,701 | $11K |
| 73610 | <1% | 1,335 | $11K | |
| 73562 | <1% | 1,550 | $10K | |
| 82728 | <1% | 1,111 | $10K | |
| 90620 | <1% | 438 | $10K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 33 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,692 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,724 | $9K |
| 86920 | <1% | 336 | $9K | |
| 73030 | <1% | 841 | $8K | |
| 82746 | <1% | 836 | $8K | |
| 0001A | <1% | 874 | $8K | |
| 90723 | <1% | 537 | $8K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,737 | $7K |
| 84702 | <1% | 3,387 | $7K | |
| 87070 | <1% | 925 | $7K | |
| 96130 | <1% | 174 | $6K | |
| 73110 | <1% | 721 | $6K | |
| 90836 | <1% | 49 | $6K | |
| 88341 | <1% | 39 | $5K | |
| 73130 | <1% | 1,105 | $5K | |
| 90698 | <1% | 358 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,047 | $5K |
| 92551 | <1% | 88 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 98 | $5K |
| 29530 | <1% | 12 | $5K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 226 | $5K |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 64 | $5K |
| 90461 | <1% | 420 | $4K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $4K |
| 15853 | <1% | 71 | $4K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 35 | $4K |
| 99173 | <1% | 94 | $4K | |
| 92133 | <1% | 44 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $4K |
| 87340 | <1% | 1,356 | $4K | |
| 83735 | <1% | 8,771 | $4K | |
| 86706 | <1% | 717 | $3K | |
| 90707 | <1% | 204 | $3K | |
| 90710 | <1% | 148 | $3K | |
| 81243 | <1% | 133 | $3K | |
| J3490 | Unclassified drugs | <1% | 859 | $3K |
| 86592 | <1% | 2,649 | $3K | |
| 86762 | <1% | 419 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 25 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,315 | $3K |
| 84100 | <1% | 5,792 | $3K | |
| 83540 | <1% | 723 | $3K | |
| 94010 | <1% | 17 | $3K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 12 | $3K |
| 72128 | <1% | 63 | $3K | |
| 83550 | <1% | 694 | $3K | |
| 83690 | <1% | 7,127 | $3K | |
| 83020 | <1% | 368 | $3K | |
| 81401 | <1% | 108 | $3K | |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | <1% | 110 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 25 | $2K |
| A0425 | Ground mileage, per statute mile | <1% | 670 | $2K |
| C1769 | Guide wire | <1% | 12 | $2K |
| 94760 | <1% | 19,795 | $2K | |
| 70496 | <1% | 13 | $2K | |
| 81244 | <1% | 133 | $2K | |
| 96138 | <1% | 74 | $2K | |
| 94060 | <1% | 70 | $2K | |
| 92250 | <1% | 27 | $2K | |
| 87088 | <1% | 2,927 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,274 | $2K |
| 86803 | <1% | 319 | $2K | |
| 97165 | <1% | 15 | $2K | |
| 0004A | <1% | 51 | $2K | |
| G9035 | Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) | <1% | 12 | $1K |
| 90716 | <1% | 115 | $1K | |
| 73590 | <1% | 340 | $1K | |
| 99401 | <1% | 48 | $1K | |
| 86140 | <1% | 1,162 | $1K | |
| 84484 | <1% | 5,995 | $1K | |
| 84703 | <1% | 2,068 | $1K | |
| 72170 | <1% | 502 | $1K | |
| 94729 | <1% | 72 | $1K | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 12 | $1K |
| 87040 | <1% | 698 | $1K | |
| 90696 | <1% | 78 | $1K | |
| 92134 | <1% | 13 | $1K | |
| 73090 | <1% | 188 | $1K | |
| 96368 | <1% | 185 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,084 | $916.31 |
| 90700 | <1% | 69 | $890.41 | |
| 73080 | <1% | 187 | $819.40 | |
| 80164 | <1% | 91 | $817.76 | |
| 96139 | <1% | 70 | $797.18 | |
| J1815 | Injection, insulin, per 5 units | <1% | 791 | $707.66 |
| 99201 | <1% | 15 | $703.66 | |
| 83615 | <1% | 217 | $667.30 | |
| 96367 | <1% | 61 | $644.43 | |
| 82652 | <1% | 33 | $606.03 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 746 | $602.36 |
| 94727 | <1% | 58 | $579.84 | |
| 85651 | <1% | 904 | $555.20 | |
| 85379 | <1% | 1,326 | $482.22 | |
| 90647 | <1% | 34 | $464.10 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,997 | $463.32 |
| 82570 | <1% | 245 | $435.35 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,838 | $426.07 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 28 | $418.58 |
| 80320 | <1% | 2,529 | $408.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,822 | $397.57 |
| 82550 | <1% | 1,171 | $396.63 | |
| 94761 | <1% | 284 | $367.96 | |
| 83605 | <1% | 2,098 | $336.33 | |
| 88313 | <1% | 171 | $334.27 | |
| 82042 | <1% | 204 | $315.98 | |
| 90744 | <1% | 25 | $314.29 | |
| 81002 | <1% | 123 | $305.25 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,106 | $297.55 |
| 80329 | <1% | 837 | $275.41 | |
| 74018 | <1% | 66 | $275.14 | |
| 84436 | <1% | 74 | $247.20 | |
| 96127 | <1% | 160 | $202.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,238 | $190.47 |
| 84425 | <1% | 12 | $169.70 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 429 | $158.76 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 423 | $120.57 |
| 83527 | <1% | 14 | $112.50 | |
| 85045 | <1% | 61 | $111.02 | |
| 83525 | <1% | 15 | $87.50 | |
| 73502 | <1% | 26 | $74.35 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,746 | $63.31 |
| 81000 | <1% | 120 | $63.15 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 560 | $61.42 |
| 90656 | <1% | 44 | $60.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,025 | $55.79 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 509 | $54.91 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,747 | $54.52 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 588 | $52.49 |
| 82947 | <1% | 27 | $45.60 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,017 | $42.42 |
| 84479 | <1% | 27 | $39.60 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,796 | $27.48 |
| 87081 | <1% | 24 | $25.65 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12 | $21.91 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 29 | $21.90 |
| 96376 | <1% | 96 | $19.81 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,332 | $12.25 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 306 | $8.41 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 392 | $6.42 |
| 82565 | <1% | 14 | $5.03 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 731 | $4.38 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 108 | $2.44 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 340 | $2.31 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 532 | $1.03 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 109 | $0.56 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 294 | $0.16 |
| 99080 | 0% | 1,307 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 17 | $0.00 |
| 73140 | 0% | 13 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREN, ROBERT (VP REVENUE CYCLE)